Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Li X, Qu ZC, May JM
In those with T2DM who continue to have an A1C above target despite dual/triple therapy with metformin and other antidiabetic agents, the GLP-1 receptor agonists and dual agonists are preferred injectable medications to insulin due to similar or even better efficacy in A1C reduction, lower risk of hypoglycemia, and cardiovascular and renal protective benefits
If you notice persistent redness or swelling from previous injections, consult your PlexusDx provider before continuing
Milbank Quarterly, 102(2), 336350
US$ 26.51
US$ 22.05
US$ 21.93
